ARID1B and neoplasm: Lastly, we established subcutaneous tumor models of the VOA1066 cell line (cell line xenograft (CDX)) and a novel PDX, XVOA14590, derived from a human DDEC primary tumor lacking both ARID1A and ARID1B expression (Extended Data Fig. 7A).